Search details
1.
Mucosal vaccine-induced cross-reactive CD8+ T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection.
Nat Immunol
; 25(3): 537-551, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38337035
2.
Author Correction: Mucosal vaccine-induced cross-reactive CD8+ T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection.
Nat Immunol
; 25(3): 578, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38360936
3.
Adenoviral vectors infect B lymphocytes in vivo.
Mol Ther
; 31(9): 2600-2611, 2023 09 06.
Article
in English
| MEDLINE | ID: mdl-37452494
4.
A New Gorilla Adenoviral Vector with Natural Lung Tropism Avoids Liver Toxicity and Is Amenable to Capsid Engineering and Vector Retargeting.
J Virol
; 94(10)2020 05 04.
Article
in English
| MEDLINE | ID: mdl-32102889
5.
Retraction Notice to: Insulin-like Growth Factor-binding Protein-7 (IGFBP7): A Promising Gene Therapeutic for Hepatocellular Carcinoma (HCC).
Mol Ther
; 31(2): 599, 2023 02 01.
Article
in English
| MEDLINE | ID: mdl-36587625
6.
Adenovirus vector expressing Stx1/Stx2-neutralizing agent protects piglets infected with Escherichia coli O157:H7 against fatal systemic intoxication.
Infect Immun
; 83(1): 286-91, 2015 Jan.
Article
in English
| MEDLINE | ID: mdl-25368111
7.
Monitoring of biodistribution and persistence of conditionally replicative adenovirus in a murine model of ovarian cancer using capsid-incorporated mCherry and expression of human somatostatin receptor subtype 2 gene.
Mol Imaging
; 132014.
Article
in English
| MEDLINE | ID: mdl-25249483
8.
Insulin-like growth factor-binding protein-7 (IGFBP7): a promising gene therapeutic for hepatocellular carcinoma (HCC).
Mol Ther
; 21(4): 758-66, 2013 Apr.
Article
in English
| MEDLINE | ID: mdl-23319057
9.
A phase I clinical trial of Ad5/3-Δ24, a novel serotype-chimeric, infectivity-enhanced, conditionally-replicative adenovirus (CRAd), in patients with recurrent ovarian cancer.
Gynecol Oncol
; 130(3): 518-24, 2013 Sep.
Article
in English
| MEDLINE | ID: mdl-23756180
10.
Engineering a Novel Modular Adenoviral mRNA Delivery Platform Based on Tag/Catcher Bioconjugation.
Viruses
; 15(11)2023 Nov 20.
Article
in English
| MEDLINE | ID: mdl-38005953
11.
A bivalent ChAd nasal vaccine protects against SARS-CoV-2 BQ.1.1 and XBB.1.5 infection and disease in mice and hamsters.
bioRxiv
; 2023 May 04.
Article
in English
| MEDLINE | ID: mdl-37205450
12.
Mucosal Adenoviral-vectored Vaccine Boosting Durably Prevents XBB.1.16 Infection in Nonhuman Primates.
bioRxiv
; 2023 Nov 08.
Article
in English
| MEDLINE | ID: mdl-37986823
13.
Efficient Genome Editing Achieved via Plug-and-Play Adenovirus Piggyback Transport of Cas9/gRNA Complex on Viral Capsid Surface.
ACS Nano
; 16(7): 10443-10455, 2022 07 26.
Article
in English
| MEDLINE | ID: mdl-35749339
14.
Evaluation of tumor immunity after administration of conditionally replicative adenoviral vector in canine osteosarcoma patients.
Heliyon
; 7(2): e06210, 2021 Feb.
Article
in English
| MEDLINE | ID: mdl-33615011
15.
Advanced genetic engineering to achieve in vivo targeting of adenovirus utilizing camelid single domain antibody.
J Control Release
; 334: 106-113, 2021 06 10.
Article
in English
| MEDLINE | ID: mdl-33872627
16.
Targeting Tumor Neoangiogenesis via Targeted Adenoviral Vector to Achieve Effective Cancer Gene Therapy for Disseminated Neoplastic Disease.
Mol Cancer Ther
; 19(3): 966-971, 2020 03.
Article
in English
| MEDLINE | ID: mdl-31907220
17.
A Gorilla Adenovirus-Based Vaccine against Zika Virus Induces Durable Immunity and Confers Protection in Pregnancy.
Cell Rep
; 28(10): 2634-2646.e4, 2019 09 03.
Article
in English
| MEDLINE | ID: mdl-31484074
18.
Defining a murine ovarian cancer model for the evaluation of conditionally-replicative adenovirus (CRAd) virotherapy agents.
J Ovarian Res
; 12(1): 18, 2019 Feb 15.
Article
in English
| MEDLINE | ID: mdl-30767772
19.
Development of an adenovirus vector vaccine platform for targeting dendritic cells.
Cancer Gene Ther
; 25(1-2): 27-38, 2018 02.
Article
in English
| MEDLINE | ID: mdl-29242639
20.
Adenovirus platform enhances transduction efficiency of human mesenchymal stem cells: An opportunity for cellular carriers of targeted TRAIL-based TR3 biologics in ovarian cancer.
PLoS One
; 12(12): e0190125, 2017.
Article
in English
| MEDLINE | ID: mdl-29267342